Skip to main content
Premium Trial:

Request an Annual Quote

Empire Genomics Licenses Biomarker from Emory University for Multiple Myeloma CDx

NEW YORK (GenomeWeb News) – Empire Genomics said today that it has acquired the exclusive license to a genomic biomarker from Emory University for the development of a molecular diagnostic test for determining which therapies may be most suitable for specific patients with multiple myeloma.

A phase II biomarker-driven clinical trial is being conducted using the technology to validate its ability to predict outcomes of new generations of drugs for the blood cell cancer, Empire Genomics said.

The Buffalo, NY-based firm is commercializing the test, and plans to use the biomarker in lymphoma patients as part of its effort to support and accelerate clinical trials and create cancer companion diagnostics. It anticipates launching the test through clinical laboratories in early 2013.

"Developing a clinically validated multiple myeloma cancer theranostic assay with informative data will represent a major breakthrough in improving disease management," Leon Bernal-Mizrachi, an assistant professor of hematology and medical oncology at the Emory University School of Medicine, said in a statement. "It would fulfill an unmet medical need to help patients with multiple myeloma better plan treatment options that will help produce the best outcomes."

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.